2026. COST-EFFECTIVENESS ANALYSIS OF AUGMENTIN 625 MG AND AUCLANITYL 500 MG/125 MG IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA. Vietnam Journal of Community Medicine. 67, CD15 (Sept. 2026). DOI:https://doi.org/10.52163/yhc.v67iCD15.6792.